EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential

Kaushik Das iD, Subhojit Paul, Arnab Ghosh, Saurabh Gupta iD, Tanmoy Mukherjee iD, Prem Shankar iD, Anshul Sharma, Shiva Keshava iD, Subhash C Chauhan, Vivek Kumar Kashyap, Deepak Parashar iD

Cancers · 07.10.2023 · 15 (19) · 4879

DOI: 10.3390/cancers15194879 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.10.2023. Verfasst von Kaushik Das und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, The University of Texas at Tyler Health Science Center, Tyler, TX 75708, USA. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple–negative breast cancer (TNBC) is an aggressive subtype accounting for ~10–20% of all human BC and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) amplification. Owing to its unique molecular profile and limited targeted therapies, TNBC treatment poses significant challenges. Unlike other BC subtypes, TNBC lacks specific molecular targets, rendering endocrine therapies and HER2–targeted treatments ineffective. The chemotherapeutic regimen is the predominant systemic treatment modality for TNBC in current clinical practice. However, the efficacy of chemotherapy in TNBC is variable, with response rates varying between a wide range of patients, and the emerging resistance further adds to the difficulties. Furthermore, TNBC exhibits a higher mutational burden and is acknowledged as the most immunogenic of all BC subtypes. Consequently, the application of immune checkpoint inhibition has been investigated in TNBC, yielding promising outcomes. Recent evidence identified extracellular vesicles (EVs) as an important contributor in the context of TNBC immunotherapy. In view of the extraordinary ability of EVs to transfer bioactive molecules, such as proteins, lipids, DNA, mRNAs, and small miRNAs, between the cells, EVs are considered a promising diagnostic biomarker and novel drug delivery system among the prospects for immunotherapy. The present review provides an in–depth understanding of how EVs influence TNBC progression, its immune regulation, and their contribution as a predictive biomarker for TNBC. The final part of the review focuses on the recent key advances in immunotherapeutic strategies for better understanding the complex interplay between EVs and the immune system in TNBC and further developing EV–based targeted immunotherapies.

Schlagwörter

Stichwörter der Autor:innen

biomarkerbreast cancer subtypescancer progressionclassificationextracellular vesiclesimmune regulationimmunotherapytriple negative breast cancer

Autor:innen und Institutionen

  • Department of Cellular and Molecular Biology, The University of Texas at Tyler Health Science Center, Tyler, TX 75708, USA.
  • School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700012, India.
  • Department of Biotechnology, GLA University, Mathura 281406, India.
  • School of Medicine, The University of Texas at Tyler Health Science Center, Tyler, TX 75708, USA.
  • Department of Neurobiology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

ORCID-Profile: Kaushik Das, Saurabh Gupta, Tanmoy Mukherjee, Prem Shankar, Shiva Keshava, Deepak Parashar

Zitieren

APA

Das, K., Paul, S., Ghosh, A., Gupta, S., Mukherjee, T., Shankar, P., Sharma, A., Keshava, S., Chauhan, S. C., Kashyap, V. K., & Parashar, D. (2023). Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. Cancers, 15(19), 4879. https://doi.org/10.3390/cancers15194879

Vancouver

Das K, Paul S, Ghosh A, Gupta S, Mukherjee T, Shankar P, et al. Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. Cancers. 2023;15(19):4879. doi:10.3390/cancers15194879

BibTeX
@article{Das2023,
  author = {Das, Kaushik and Paul, Subhojit and Ghosh, Arnab and Gupta, Saurabh and Mukherjee, Tanmoy and Shankar, Prem and Sharma, Anshul and Keshava, Shiva and Chauhan, Subhash C and Kashyap, Vivek Kumar and Parashar, Deepak},
  title = {Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {4879},
  doi = {10.3390/cancers15194879}
}
Kostenlos starten →